Conference Coverage
Conference Coverage
Hodgkin's Survivors Face High Breast Cancer Risk
Major Finding: Nearly a third (30%) of females treated with chest radiation for Hodgkin’s lymphoma was diagnosed with breast cancer by age 50.Data...
Conference Coverage
T-DM1 Tops Capecitabine-Lapatinib in Advanced HER2-Positive Breast Cancer
Major Finding: Median progression-free survival was longer with T-DM1 than with capecitabine plus lapatinib (9.6 vs.
Conference Coverage
Docs Need Primer on Long-Term Effects of Chemotherapy
Major Finding: Only 6% of primary care physicians were able to identify the main long-term effects of doxorubicin, paclitaxel, oxaliplatin and...
Conference Coverage
Vitamin D Deficiency/Breast Cancer Link Questioned
Major Finding: Serum vitamin D levels measured before diagnosis of breast cancer showed no significant association with breast cancer risk.Data...
Conference Coverage
Acupuncture Flops as Relief for Muscle Pain From Aromatase Inhibitors
Major Finding: Eight weekly sessions of real or sham acupuncture resulted in similar improvements in pain and HAQ-DI scores in postmenopausal...
Conference Coverage
Recent Diabetes Increases Breast Cancer Risk
Major Finding: Swedish breast cancer patients were 37% more likely than controls to have been diagnosed with diabetes within the previous 4 years....
Conference Coverage
ZO-FAST: Immediate Zoledronic Acid Beats Delayed Tx in Early Breast Cancer
Major Finding: Immediate treatment with zoledronic acid reduced recurrence and mortality risk by 34% and 31%, respectively, and improved bone...
Conference Coverage
BOLERO-2: Everolimus Plus Exemestane Delays Breast Cancer Progression
Major Finding: According to updated results median progression-free survival was 7.4 months for combination therapy patients and 3.2 months for...